Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-14.06	23.64	27.51
Graham Fair Price	-16.69	27.46	32.96
PEG	309.13	-0.82	0.20
Price/Book	15.20	1.24	1.08
Price/Cash Flow	50.98	-27.90	-56.90
Prices/Earnings	57.38	23.69	15.05
Price/Sales	15.13	8.15	7.08
Price/FCF	50.98	-27.90	-56.90
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.73	0.30	0.28
Operating Margin	38.00	0.28	0.20
ROA	-31.58	< 0.005	< 0.005
ROE	0.02	0.01	-26.80
ROIC	0.01	0.02	39.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.03	4.74
Dividends QOQ	-0.02	0.02	28.97
EBIT QOQ	0.49	0.34	-30.70
EPS QOQ	0.75	-0.29	-61.53
FCF QOQ	0.21	-1.28	512.43
Revenue QOQ	0.14	-0.03	-79.35
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	89.70	99.32	10.73
Days Sales Outstanding (DSO)	47.98	52.65	9.74
Inventory Turnover	1.00	0.91	-9.69
Debt/Capitalization	0.27	0.29	4.88
Quick Ratio	0.50	0.74	48.26
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	51.94	50.58	-2.62
Cash	1.43	2.50	74.70
Capex	-2.54	-2.13	16.28
Free Cash Flow	-0.98	-2.25	-128.82
Revenue	7.91	7.70	-2.56
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.10	1.49	35.43
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.22	5.64	-21.90
Naive Interpretation	Member

06 - Financial Health · Weak

Rating